Oncology Nursing News®

Breast Cancer

AE Management and Adherence Is Key in Breast Cancer Treatment

AE Management and Adherence Is Key in Breast Cancer Treatment

BY HAYLEY VIRGIL

FDA Accepts 2 New Supplemental Biologics License Applications for Pembrolizumab in TNBC

FDA Accepts 2 New Supplemental Biologics License Applications for Pembrolizumab in TNBC

BY HANNAH SLATER

More Personalized Treatment Needed for Early Stage HER2+ Breast Cancer

More Personalized Treatment Needed for Early Stage HER2+ Breast Cancer

BY BRITTANY COTE

F-627 Shows Strong, Beneficial for Chemotherapy-Induced Neutropenia in Breast Cancer

F-627 Shows Strong, Beneficial for Chemotherapy-Induced Neutropenia in Breast Cancer

BY KRISTI ROSA

HER2+ Breast Cancer With Brain Metastases: Unmet Needs Remain

HER2+ Breast Cancer With Brain Metastases: Unmet Needs Remain

BY BRITTANY COTE

FDA Approves Phesgo, an In-Home Breast Cancer Treatment

FDA Approves Phesgo, an In-Home Breast Cancer Treatment

BY BRIELLE BENYON

PIK3A-Mutant Breast Cancer Shows Increased Sensitivity to PI3Kα Inhibition

PIK3A-Mutant Breast Cancer Shows Increased Sensitivity to PI3Kα Inhibition

BY BRITTANY LOVELY

Helping Breast Cancer Survivors Deal With Body Image Issues

Helping Breast Cancer Survivors Deal With Body Image Issues

BY DEBI FISCHER, MSW, BSN, BA, LCSW, RN

An Ounce of Prevention: Nurses Educate Patients, Reduce Disparities Through Community Outreach

An Ounce of Prevention: Nurses Educate Patients, Reduce Disparities Through Community Outreach

BY LINDA CHILDERS

Identifying the Needs of Men With Breast Cancer

Identifying the Needs of Men With Breast Cancer

BY CANCERCARE

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.